Results 291 to 300 of about 3,591,939 (354)

Pharmacovigilance evidence of drug induced urinary incontinence in the FDA adverse event reporting system. [PDF]

Sci Rep
Li C, Wu C, Cai S, Wang L.
europepmc   +1 more source

Adverse events associated with use of immunoglobulin in pediatric patients reported to the US Food and Drug Administration Adverse Event Reporting System, 2001-2023. [PDF]

Pediatr Allergy Immunol
Wei S, Kim Y, Rubin MN, Ayyala SS, Welsh K.   +4 more
europepmc   +1 more source

A Real-World Pharmacovigilance Study of Fruquintinib Based on the FDA Adverse Event Reporting System (FAERS) Database. [PDF]

Cancer Med
Xu Y, Wang D, Xu Y.
europepmc   +1 more source

"Adaptive learning-guidance system with multi-sensory feedback" : final report on the sub-project of in-tech GmbH within the joint research project ILehLe

, 2019
Frank Höwing
openalex  

Real-world safety of Tepotinib: Insights from the Food and Drug Administration Adverse Event Reporting System. [PDF]

PLoS One
Wei S, Zhang L, Liu C, Qi X.
europepmc   +1 more source

Molecular Reporter Systems

, 2005
openaire   +1 more source

Molecular Reporter Systems

, 2020
openaire   +1 more source

Drug-induced dermatomyositis: a pharmacovigilance study of the FDA adverse event reporting system. [PDF]

Front Pharmacol
Bi J, Xie H, Yang Y, Chen Q, Cui B, Xiao Z.   +5 more
europepmc   +1 more source

Consolidated report system

, 2015
openaire   +1 more source